Book contents
- Anesthesia Oral Board Review
- Anesthesia Oral Board Review
- Copyright page
- Contents
- Contributors
- Acknowledgments
- Letter from the Associate Editor
- How to Use This Book
- Format
- Applied Exam Tips for Success
- Part I General Information
- Part II Anesthetic-Related Critical Events and Information
- Index
- References
Chapter 37 - Cardiopulmonary Bypass (CPB) and Associated Anticoagulation
from Section 2 - Cardiac, Thoracic, and Vascular Anesthesia
Published online by Cambridge University Press: 03 August 2023
Book contents
- Anesthesia Oral Board Review
- Anesthesia Oral Board Review
- Copyright page
- Contents
- Contributors
- Acknowledgments
- Letter from the Associate Editor
- How to Use This Book
- Format
- Applied Exam Tips for Success
- Part I General Information
- Part II Anesthetic-Related Critical Events and Information
- Index
- References
Summary
A 69-year-old female is scheduled to undergo a coronary revascularization, as well as an aortic valve replacement for severe aortic stenosis. Her past medical history is significant for a non-ST segment myocardial infarction (MI), hypertension, progressive aortic stenosis with mildly depressed left ventricular function, and diabetes mellitus. Her past surgical history is significant for endoscopic sinus surgery 3 years prior and a left femoral-distal bypass graft 2 years ago. She does not report any adverse anesthetic complications but does report a fall in her platelet count when she was hospitalized for lower extremity ischemia. What are your concerns? What pre-operative workup would you like? How does her medical history affect your intra-operative plans?
Information
- Type
- Chapter
- Information
- Anesthesia Oral Board ReviewKnocking Out The Boards, pp. 166 - 171Publisher: Cambridge University PressPrint publication year: 2023
References
Barash, PG, Cullen, BF, Stoelting, RK, et al. Clinical Anesthesia, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2017, pp. 1090–104.Google Scholar
Butterworth, JF, Mackey, DC, Wasnick, JD. Morgan & Mikhail’s Clinical Anesthesiology, 6th ed. New York: McGraw-Hill Education, 2018, pp. 443–94.Google Scholar
Castelli, R, Casserino, E, Cappellini, MD, et al. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. Cardiovasc Hematol Disord Drug Targets 2007;7(3):153–62.CrossRefGoogle ScholarPubMed
Despotis, GJ, Joist, JH. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. J Cardiothorac Vasc Anesth 1999;13(4 Suppl. 1):18–29.CrossRefGoogle ScholarPubMed
Despotis, GJ, Levine, V, Hoist, JH, et al. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation. Anesth Analg 1997;85(3):498–506.CrossRefGoogle ScholarPubMed
Hartmann, M, Sucker, C, Boehm, O, et al. Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006;20(3):230–41.CrossRefGoogle ScholarPubMed
Kam, PC. Anaesthetic management of a patient with thrombocytopenia. Curr Opin Anesthesia 2008;21(3):369–74.Google ScholarPubMed
Maslow, AD, Chaudrey, A, Bert, A, et al. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid. J Cardiothorac Vasc Anesth 2008;22(1):6–15.CrossRefGoogle ScholarPubMed
Miller, RD. Miller’s Anesthesia, 6th ed. Philadelphia: Churchill Livingston, 2005.Google ScholarPubMed
Ngaage, DL, Cale, A, Cowen, A, et al. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ann Thorac Surg 2008;86(4):1195–202.CrossRefGoogle ScholarPubMed
Taneja, R, Fernandes, P, Marwaha, G, et al. Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian survey. J Cardiothorac Vasc Anesth 2008;22(5):662–9.CrossRefGoogle ScholarPubMed
Warkentin, TES. Heparin-induced thrombocytopenia and the anesthesiologists. Can J Anaesth 2002;49:S36–S49.Google Scholar
Young, JA, Kisker, CT, Doty, DB. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomers. Ann Thorac Surg 1978;26:231.CrossRefGoogle Scholar
Accessibility standard: Unknown
Why this information is here
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.Accessibility Information
Accessibility compliance for the HTML of this chapter is currently unknown
and may be updated in the future.